Stockholders' Equity (Details 1) - Warrants [Member] |
6 Months Ended |
|---|---|
|
Aug. 05, 2018
$ / shares
shares
| |
| Average Exercise Price, Outstanding, Beginning | $ / shares | $ 17.18 |
| Average Exercise Price, Warrants Issued | $ / shares | 19.05 |
| Average Exercise Price, Expired and canceled | $ / shares | 17.18 |
| Average Exercise Price, Warrants Outstanding, Ending | $ / shares | $ 16.83 |
| Number of warrants, Outstanding, Beginning | shares | 930,054 |
| Number of warrants, Warrants issued | shares | 1,080,725 |
| Number of warrants, Expired and canceled | shares | (930,054) |
| Number of warrants, Warrants Outstanding, Ending | shares | 1,080,725 |
| Weighted average remaining contractual life (yrs), Outstanding, Beginning | 3 years 2 months 27 days |
| Weighted average remaining contractual life (yrs), Warrants Issued | 3 years 8 months 2 days |
| Weighted average remaining contractual life (yrs), Expired and canceled | 3 years 2 months 12 days |
| Weighted average remaining contractual life (yrs), Warrants Outstanding, Ending | 3 years 5 months 1 day |
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired And Canceled Weighted Average Remaining Contractual Terms. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Remaining Contractual Terms. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Term2. No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|